Social Pharmacy and Clinical Pharmacy—Joining Forces

Social Pharmacy and Clinical Pharmacy—Joining Forces

This commentary seeks to define the areas of social pharmacy and clinical pharmacy to uncover what they have in common and what still sets them apart. Common threats and challenges of the two areas are reviewed in order to understand the forces in play. Forces that still keep clinical and social pharmacy apart are university structures, research traditions, and the management of pharmacy servic...

Clinical pharmacy and clinical trials

CPC-148 Table 1 adalimumab infliximab ustekinumab Lost to follow-up 5% (1/20) 23.5% (4/17) 22% (2/9) Continuing treatment 40% (8/20) 29.4% (5/17) 67% (6/9) Withdrawal/ Discontinuation by doctor 5% (1/20) 5.9% (1/17) 11% (1/9) Discontinuation due to good response 20% (4/20) – – Change of treatment 30% (6/20) 41.2% (7/17) – The causes of the discontinuation/change of treatment were: Abstract CPC-...

Social Forces

This is an attractive little volume of two hundred and twenty-six pages, neatly bound and printed upon excellent paper with wide margins and clear type. It is a literary mosaic made up of twenty-five editorials appearing in The Survey in 1907 and 1908. These more or less disconnected bits of expression upon social phenomena in general are put together with so much skill and delicacy of workmans...

Clinical pharmacy services, pharmacy staffing, and hospital mortality rates.

OBJECTIVE To determine if hospital-based clinical pharmacy services and pharmacy staffing continue to be associated with mortality rates. METHODS A database was constructed from 1998 MedPAR, American Hospital Association's Annual Survey of Hospitals, and National Clinical Pharmacy Services databases, consisting of data from 2,836,991 patients in 885 hospitals. Data from hospitals that had 14 ...

Attitudes of Doctor of Pharmacy Students Toward the Application of Social and Administrative Pharmacy in Clinical Practice